Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Tx: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931Phase 4Terminated
- Start
- Feb 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Suboxone in chronic pain and opioid use disorder (OUD). Primary endpoints: Opiate Withdrawal at 6 months and Pain Severity at 6 months. Started Feb 2013; status: terminated.
02
Drugs
Suboxone
03
Conditions
chronic painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01841931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841931.